GLP-1 Drugs Lower Risk of Death by 44% in Obesity and Autoimmune Disease
Adults with obesity and at least one autoimmune disease taking GLP-1 medication experience fewer cardiac events, are less likely to visit the ER, and have a low...
Adults with obesity and at least one autoimmune disease taking GLP-1 medication experience fewer cardiac events, are less likely to visit the ER, and have a lower risk of death. The post GLP-1 Drugs Lower Risk of Death by 44% in Obesity and Autoimmune Disease appeared first on Inside Precision Medicine .